Adoptive Cellular Immunotherapy Market

The global Adoptive Cellular Immunotherapy market size was valued at US$ 3.45 billion in 2024 and is projected to reach US$ 8.91 billion by 2030, at a CAGR of 17.1% during the forecast period 2024-2030.

United States Adoptive Cellular Immunotherapy market size was valued at US$ 1.12 billion in 2024 and is projected to reach US$ 2.79 billion by 2030, at a CAGR of 16.4% during the forecast period 2024-2030.

Immunotherapy approach using patients' own immune cells to treat cancer and other diseases.

Rapid growth driven by increasing cancer prevalence and advancements in cell therapy technologies. Rising investment in CAR-T cell therapies and TIL treatments. Ongoing clinical trials expanding potential applications in various cancer types.

Report Overview

Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.

Adoptive Cellular Immunotherapy Market provides a deep insight into the global Adoptive Cellular Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adoptive Cellular Immunotherapy Market, Adoptive Cellular Immunotherapy Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, Adoptive Cellular Immunotherapy Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adoptive Cellular Immunotherapy market in any manner.

Global Adoptive Cellular Immunotherapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Amgen Inc

Autolus Therapeutics Plc

Beijing Immunochina Medical Science & Technology Co Ltd

Bellicum Pharmaceuticals Inc

Bristol-Myers Squibb Co

bluebird bio Inc

CARsgen Therapeutics Ltd

Celgene Corp

Cell Medica Ltd

Cellular Biomedicine Group Inc

Celularity Inc

Celyad SA

Daiichi Sankyo Co Ltd

Fosun Pharmaceutical AG

Gilead Sciences Inc

Guangzhou Anjie Biomedical Technology Co Ltd

Hangzhou Converd Co Ltd

Hebei Senlang Biotechnology Inc Ltd

HRAIN Biotechnology Co Ltd

Juno Therapeutics Inc

Kite Pharma Inc

Nanjing Legend Biotech Co Ltd

NantKwest Inc

Nkarta Inc

Novartis AG

Ono Pharmaceutical Co Ltd

Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

Sorrento Therapeutics Inc

Takara Bio Inc

Market Segmentation (by Type)

TIL

LAK

CAR-T

TCR-T

CIK

NK

DC

Other

Market Segmentation (by Application)

Hospital

Cancer Hospital

Centers for Disease Control and Prevention

Rehabilitation Center

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Adoptive Cellular Immunotherapy Market

Overview of the regional outlook of the Adoptive Cellular Immunotherapy Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter